Luc Burgard

Part of Sartorius AG, Sartorius Stedim Systems GmbH is a German company that offers single-use convenience and stainless-steel performance with the GMP ready Biostat STR® Microbial fermenter equipped with Biobrain®. The company is based in Guxhagen, Germany. The CEOs are Luc Albert Raymond Burgard, Thorsten Peuker. The company was founded in 1988.

Sartorius Stedim Fmt SAS manufactures plastic packaging products. It serves to biopharmaceutical, chemical, food, and academic labs. The firm's product portfolio includes cell analysis, bioreactors, lab filtration, fluid management, and water purification. The company is headquartered in Aubagne, France.

Part of Sartorius AG, Sartorius Stedim Aseptics SAS is a French company that provides engineering services. The company is based in Lourdes, France. The company was founded in 1994. Benedicte Vonsensey has been the CEO of the company since 2017.

Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden.

Part of Recipharm AB, Wasserburger Arzneimittelwerk GmbH is a German company that manufactures injectable pharmaceuticals. The company is based in Wasserburg am Inn, Germany. The company was founded in 1989. The CEO is Michael Isele. Wasserburger Arzneimittelwerk was acquired by Recipharm AB from Hospira, Inc. on January 31, 2010.